Thermo Fisher Scientific and Hamilton Company Introduce Forensic Laboratory-Qualified Automated Nucleic Acid Extraction Platform

Thermo Fisher Scientific and Hamilton Company Introduce Forensic Laboratory-Qualified Automated Nucleic Acid Extraction Platform ID NIMBUS Presto Assay Ready Workstation Integrates Thermo Scientific KingFisher Presto Purification System with Hamilton Microlab NIMBUS for Rapid Processing of Casework Samples SOUTH SAN FRANCISCO, Calif., April 24, 2020 /PRNewswire/ — Forensic scientists now have access to the new ID NIMBUS... Read more

Brooks Automation Reports Preliminary Results for its Second Quarter of Fiscal 2020, Ended March 31, 2020 and Timing of its Second Quarter Conference Call and Webcast

Brooks Automation Reports Preliminary Results for its Second Quarter of Fiscal 2020, Ended March 31, 2020 and Timing of its Second Quarter Conference Call and Webcast CHELMSFORD, Mass., April 13, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported preliminary financial results for the second fiscal quarter of 2020, ended March 31, 2020.    Second Quarter... Read more

Brooks to Participate in the 19th Annual Needham Virtual Healthcare Conference

CHELMSFORD, Mass., April 8, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that company management will participate in the 19th Annual Needham Virtual Healthcare Conference on Tuesday, April 14, 2020 at 10:40 a.m. ET.  The 40-minute session will be webcast live via the Brooks investor relations website at www.brooks.investorroom.com/events. About Brooks AutomationBrooks (Nasdaq: BRKS)... Read more

Brooks Automation Names Erica McLaughlin to Its Board of Directors

CHELMSFORD, Mass., April 6, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today announced that Erica McLaughlin has been elected to its Board of Directors. Ms. McLaughlin, Senior Vice President and CFO of Cabot Corporation, joins the board and the audit committee, bringing deep leadership experience as a global public company CFO and a background in public... Read more

New Instrument Fully Automates Sample Preparation for PFAS Analysis in Drinking Water

New Instrument Fully Automates Sample Preparation for PFAS Analysis in Drinking Water Designed for EPA method 537.1, the Thermo Scientific Dionex AutoTrace 280 PFAS Solid-Phase Extraction Instrument delivers reliable, consistent sample preparation for the determination of PFAS in drinking water SUNNYVALE, Calif., March 31, 2020 /PRNewswire/ — A new instrument that fully automates sample preparation for... Read more

QIAGEN receives U.S. FDA EUA for QIAstat-Dx test kit, first and only syndromic solution integrating detection of SARS-CoV-2 coronavirus

Germantown, Maryland, and Hilden, Germany, March 31, 2020 –QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its newly developed QIAstat-Dx Respiratory SARS-CoV-2 Panel test for use in diagnosing patients infected with the novel COVID-19 coronavirus. The QIAstat-Dx... Read more

Luminex Receives FDA Emergency Use Authorization for NxTAG® CoV Extended Panel to Detect the SARS-CoV-2 Virus that Causes COVID-19 Disease

AUSTIN, Texas, March 27, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its NxTAG® CoV Extended Panel. The intended use of this multiplex test is the detection of the SARS-CoV-2 virus. High complexity molecular laboratories can now use the NxTAG test... Read more

Notification

EUROIMMUN is one of the first European manufacturers of diagnostic tests to provide CE-marked antibody detection systems to support COVID-19 diagnostics. The Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN, a PerkinElmer, Inc.  company (NYSE:PKI), have received the CE mark and can now be applied to COVID-19 diagnostics. The PCR test EURORealTime SARS-CoV-2... Read more

EUROIMMUN is one of first European manufacturers of diagnostic tests to provide CE-marked antibody detection systems to support COVID-19 diagnostics

The Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN, a PerkinElmer, Inc.  company (NYSE:PKI), have received the CE mark and can now be applied to COVID-19 diagnostics. The PCR test EURORealTime SARS-CoV-2 has been submitted for CE mark. COVID-19 is currently significantly affecting the lives of people worldwide. At the end of January... Read more

QIAGEN releases QIAstat-Dx test kit to the U.S. as first syndromic test for detection of SARS-CoV-2 coronavirus under new FDA Policy

Germantown, Maryland, and Hilden, Germany, March 24, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has begun shipments to the United States of its new QIAstat-Dx Respiratory SARS-CoV-2 Panel test to aid in diagnosing patients infected with the novel COVID-19 coronavirus under a new Policy of the U.S. Food and... Read more